Real time Form 13D and 13G transaction reports:
- Schedule 13D must be filed within ten days after a person or an organization acquires beneficial ownership of more than 5% of a voting class of a company's equity securities.
- Due to inconsistent filing format, it is highly recommended that you read the orignal filing form.
- Shares have beem adjusted for stock split.
"Insiders might sell their shares for any number of reasons, but they buy them for only one: they think the price will rise"
- Peter Lynch
What is insider trading>>
- Peter Lynch
What is insider trading>>
| Reported DateTime | Transaction Date | Type | Company Symbol | Filed By Symbol | Shares Owned % Owned | Shares Vs. Prev Report | View |
| 2026-02-17 9:26 pm Purchase | 2026-02-10 | 13D | ERNEXA THERAPEUTICS INC ERNA | Charles Cherington | 10,791,335 34.700% | 8,011,950 (+288.26%) | Filing History |
| 2025-06-11 8:39 pm Purchase | 2025-06-09 | 13D | ERNEXA THERAPEUTICS INC ERNA | Charles Cherington | 2,779,385 37.900% | 1,417,209 (+104.04%) | Filing History |
| 2025-04-04 10:55 am Purchase | 2025-04-02 | 13D | ERNEXA THERAPEUTICS INC ERNA | Charles Cherington | 1,362,176 32.800% | 252,697 (+22.78%) | Filing History |
| 2025-03-05 5:55 pm Purchase | 2024-10-29 | 13D | ERNEXA THERAPEUTICS INC ERNA | Charles Cherington | 1,109,479 32.380% | 1,028,644 (+1272.52%) | Filing History |
| 2024-01-05 7:16 pm Purchase | 2023-12-27 | 13D | COMERA LIFE SCIENCE HLDGS INC CMRA | Charles Cherington | 45,989,871 66.310% | 32,000,317 (+228.74%) | Filing History |
| 2023-12-22 12:05 pm Unchanged | 2023-12-14 | 13D | ERNEXA THERAPEUTICS INC ERNA | Charles Cherington | 80,835 19.990% | 0 (Unchanged) | Filing History |
| 2023-09-07 8:05 pm Purchase | 2023-08-31 | 13D | COMERA LIFE SCIENCE HLDGS INC CMRA | Charles Cherington | 13,989,554 37.450% | 8,568,949 (+158.08%) | Filing History |
| 2023-09-07 5:26 pm Purchase | 2023-07-13 | 13D | ERNEXA THERAPEUTICS INC ERNA | Charles Cherington | 80,835 19.990% | 43,000 (+113.65%) | Filing History |
| 2023-08-25 8:40 pm Purchase | 2023-07-31 | 13D | COMERA LIFE SCIENCE HLDGS INC CMRA | Charles Cherington | 5,420,605 19.990% | 986,195 (+22.24%) | Filing History |
| 2023-01-06 4:36 pm Purchase | 2023-01-02 | 13D | COMERA LIFE SCIENCE HLDGS INC CMRA | Charles Cherington | 4,434,410 18.700% | 2,304,636 (+108.21%) | Filing History |
| 2022-12-14 4:30 pm Sale | 2022-12-02 | 13D | ERNEXA THERAPEUTICS INC ERNA | Charles Cherington | 37,835 11.050% | -356,389 (-90.40%) | Filing History |
| 2022-09-13 09:42 am Purchase | 2022-05-19 | 13D | COMERA LIFE SCIENCE HLDGS INC CMRA | Charles Cherington | 2,129,774 11.200% | 2,129,774 (New Position) | Filing History |
| 2022-03-16 4:30 pm Sale | 2022-03-09 | 13D | BROOKLYN IMMUNO THERAPEUTICS L ERNAW | Charles Cherington | 5,913,365 11.400% | -399,932 (-6.33%) | Filing History |
| 2021-05-13 5:00 pm Purchase | 2021-03-25 | 13D | BROOKLYN IMMUNO THERAPEUTICS L ERNAW | Charles Cherington | 6,313,297 15.200% | 6,313,297 (New Position) | Filing History |